JP2017513885A5 - - Google Patents

Download PDF

Info

Publication number
JP2017513885A5
JP2017513885A5 JP2016564031A JP2016564031A JP2017513885A5 JP 2017513885 A5 JP2017513885 A5 JP 2017513885A5 JP 2016564031 A JP2016564031 A JP 2016564031A JP 2016564031 A JP2016564031 A JP 2016564031A JP 2017513885 A5 JP2017513885 A5 JP 2017513885A5
Authority
JP
Japan
Prior art keywords
metal
compound
item
formula
items
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016564031A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017513885A (ja
JP6474430B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/027647 external-priority patent/WO2015167969A1/en
Publication of JP2017513885A publication Critical patent/JP2017513885A/ja
Publication of JP2017513885A5 publication Critical patent/JP2017513885A5/ja
Application granted granted Critical
Publication of JP6474430B2 publication Critical patent/JP6474430B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016564031A 2014-04-28 2015-04-24 Ｐｄｅ１０阻害剤の調製のための方法および中間体 Active JP6474430B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461985400P 2014-04-28 2014-04-28
US61/985,400 2014-04-28
PCT/US2015/027647 WO2015167969A1 (en) 2014-04-28 2015-04-24 Processes and intermediates for the preparation of a pde10 inhibitor

Publications (3)

Publication Number Publication Date
JP2017513885A JP2017513885A (ja) 2017-06-01
JP2017513885A5 true JP2017513885A5 (cg-RX-API-DMAC7.html) 2018-06-07
JP6474430B2 JP6474430B2 (ja) 2019-02-27

Family

ID=54359190

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016564031A Active JP6474430B2 (ja) 2014-04-28 2015-04-24 Ｐｄｅ１０阻害剤の調製のための方法および中間体

Country Status (13)

Country Link
US (2) US9650368B2 (cg-RX-API-DMAC7.html)
EP (1) EP3137462B1 (cg-RX-API-DMAC7.html)
JP (1) JP6474430B2 (cg-RX-API-DMAC7.html)
KR (1) KR102496552B1 (cg-RX-API-DMAC7.html)
CN (1) CN106459026B (cg-RX-API-DMAC7.html)
AU (1) AU2015253464B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016025287B1 (cg-RX-API-DMAC7.html)
CA (1) CA2946756C (cg-RX-API-DMAC7.html)
ES (1) ES2723437T3 (cg-RX-API-DMAC7.html)
IL (1) IL248585B (cg-RX-API-DMAC7.html)
NZ (2) NZ716494A (cg-RX-API-DMAC7.html)
RU (1) RU2718863C2 (cg-RX-API-DMAC7.html)
WO (1) WO2015167969A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2544679T3 (pl) * 2010-03-12 2019-10-31 Omeros Corp Inhibitory PDE10 oraz powiązane kompozycje i sposoby
NZ716462A (en) * 2014-04-28 2017-11-24 Omeros Corp Optically active pde10 inhibitor
US9920045B2 (en) 2015-11-04 2018-03-20 Omeros Corporation Solid state forms of a PDE10 inhibitor

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK178590D0 (da) 1990-07-26 1990-07-26 Novo Nordisk As 1,4-disubstituerede piperaziner
PT100905A (pt) 1991-09-30 1994-02-28 Eisai Co Ltd Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem
RU95113454A (ru) 1992-12-02 1997-06-10 Пфайзер Инк. (US) Катехольные диэфиры как селективные ингибиторы фдэiv, фармацевтическая композиция, способы лечения
DE4323192A1 (de) 1993-07-10 1995-01-12 Basf Ag Verfahren zur Herstellung von Homo- und Copolymerisaten von Alk-1-enen
DE4325846C1 (de) 1993-07-31 1995-01-19 Herberts Gmbh Verwendung von Furan-modifizierten aromatischen Pinakolderivaten als Initiatoren und Furan-modifizierte aromatische Pinakolderivate als solche
DE4343286A1 (de) 1993-12-17 1995-06-22 Hoechst Ag Heteroaromatische Verbindungen und ihre Verwendung in flüssigkristallinen Mischungen
DE4409501A1 (de) 1994-03-19 1995-09-21 Didier Werke Ag Verschleißfutter eines Schachtofens und Stein hierfür
AU695230B2 (en) 1994-06-24 1998-08-06 Euro-Celtique S.A. Compounds for and method of inhibiting phosphodiesterase IV
US5789434A (en) 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
TW424087B (en) 1995-04-06 2001-03-01 Janssen Pharmaceutica Nv 1,3-dihydro-1-(phenylalkenyl)-2H-imidazol-2-one derivatives
TW332201B (en) 1995-04-06 1998-05-21 Janssen Pharmaceutica Nv 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives
US6037370A (en) 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
EA199800650A1 (ru) 1996-01-22 1999-02-25 Фудзисава, Фармасьютикал Ко., Лтд Новые соединения
AU4015497A (en) 1996-08-26 1998-03-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Thiazole derivatives useful as selective inhibitors of pde-iv
JPH1087543A (ja) 1996-09-17 1998-04-07 Chisso Corp アルコキシベンゼン誘導体、液晶組成物および液晶表示素子
US6548490B1 (en) 1997-10-28 2003-04-15 Vivus, Inc. Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
WO1999045914A1 (en) 1998-03-13 1999-09-16 Maruho Kabushikikaisha Alkyl amine derivative and local anesthetic agent using the same
GB9807354D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
SE9804212D0 (sv) 1998-12-04 1998-12-04 Astra Pharma Prod Compounds
SI1165516T1 (sl) 1999-03-12 2005-02-28 Boehringer Ingelheim Pharmaceuticals Inc. Heterociklična sečnina in sorodne spojine, uporabne kot protivnetna sredstva
US7141593B1 (en) 1999-06-04 2006-11-28 Abbott Laboratories Pharmaceutical formulations
GB9929552D0 (en) 1999-12-14 2000-02-09 Proteus Molecular Design Compounds
WO2001096334A2 (en) 2000-06-15 2001-12-20 Pharmacia Corporation Heteroarylalkanoic acids as integrin receptor antagonists
US20030032579A1 (en) 2001-04-20 2003-02-13 Pfizer Inc. Therapeutic use of selective PDE10 inhibitors
JP2004530703A (ja) 2001-05-22 2004-10-07 ファイザー・プロダクツ・インク 結晶形アジスロマイシン
JP2005523360A (ja) * 2002-04-18 2005-08-04 アベシア・リミテッド 共役分子の製造および製造において使用するための物質
US6821502B2 (en) 2002-06-12 2004-11-23 Chevron U.S.A. Inc. Method of making aluminum-containing zeolite with IFR structure
WO2004011410A1 (en) 2002-07-27 2004-02-05 Astrazeneca Ab Chemical compounds
MXPA05003762A (es) 2002-10-08 2005-07-22 Scripps Research Inst Inhibidores de hidrolasa de amida de acido graso.
WO2004041258A2 (fr) 2002-10-30 2004-05-21 Neuro3D Utilisation d’inhibiteurs des phosphodiesterases des nucleotides cycliques, ayant une structure benzodiazepinique en therapie
TW200410921A (en) 2002-11-25 2004-07-01 Hoffmann La Roche Mandelic acid derivatives
EP1568691A4 (en) 2002-12-06 2010-08-25 Kowa Co ACCELERATOR FOR ERYTHROPOETIN PRODUCTION
MXPA05006727A (es) 2002-12-20 2005-09-08 Pharmacia Corp Acidos heteroarilalcanoicos como antagonistas de receptor de integrina.
WO2004071509A1 (ja) 2003-02-12 2004-08-26 Nippon Chemiphar Co., Ltd. オリゴデンドロサイト分化促進剤
AU2004232973A1 (en) 2003-04-18 2004-11-04 Memory Pharmaceuticals Corporation Pyrazole derivatives as phosphodiesterase 4 inhibitors
AR047541A1 (es) 2004-02-13 2006-01-25 Sandoz Ag Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas
NZ550114A (en) 2004-04-20 2011-02-25 Transtech Pharma Inc Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
US20060074102A1 (en) * 2004-05-14 2006-04-06 Kevin Cusack Kinase inhibitors as therapeutic agents
US7351833B2 (en) 2004-07-23 2008-04-01 Abbott Laboratories (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
US7449486B2 (en) * 2004-10-19 2008-11-11 Array Biopharma Inc. Mitotic kinesin inhibitors and methods of use thereof
US8436176B2 (en) 2004-12-30 2013-05-07 Medicis Pharmaceutical Corporation Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
UA86283C2 (uk) 2005-01-07 2009-04-10 Пфайзер Продактс Инк. Гетероароматичні сполуки хіноліну і їх застосування як інгібіторів pde10
EP1850681B1 (en) 2005-02-04 2019-12-18 Firmenich Incorporated Compounds comprising linked hetero aryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions
US20060252807A1 (en) 2005-04-22 2006-11-09 Kalypsys, Inc. Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
UA91546C2 (uk) 2005-05-03 2010-08-10 Бьорінгер Інгельхайм Інтернаціональ Гмбх КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
MY152185A (en) 2005-06-10 2014-08-29 Novartis Ag Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
EP1928848A2 (en) 2005-08-04 2008-06-11 Apogee Biothechnology Corporation Sphingosine kinase inhibitors and methods of their use
KR20080050577A (ko) 2005-08-29 2008-06-09 사노피-아벤티스 유.에스. 엘엘씨 피리다지노[4,5-ｂ]인돌 유도체의 신규 결정질 형태
US7642246B2 (en) 2005-09-13 2010-01-05 Sicor Inc. Pure rocuronium bromide
SI1954684T1 (sl) 2005-11-15 2014-07-31 Otsuka Pharmaceutical Co., Ltd. Oksazolna spojina in farmacevtski sestavek
EP1968946A4 (en) 2005-12-23 2010-05-05 Astrazeneca Ab IMIDAZOLE AS MODULATORS OF THE GABA B RECEPTOR
JP2009535394A (ja) 2006-05-02 2009-10-01 ファイザー・プロダクツ・インク Ｐｄｅ１０阻害剤としての二環式ヘテロアリール化合物
US20080090834A1 (en) 2006-07-06 2008-04-17 Pfizer Inc Selective azole pde10a inhibitor compounds
US20080234345A1 (en) 2006-09-08 2008-09-25 Gene Logic Inc. Method for reducing or alleviating inflammation in the digestive tract
SG185979A1 (en) 2006-09-25 2012-12-28 Ptc Therapeutics Inc Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid
EP2079462A4 (en) 2006-09-28 2009-12-02 Merck & Co Inc PHARMACEUTICAL COMPOSITIONS OF HDAC INHIBITORS AND CHELABLE METAL COMPOUNDS AND METALO HDAC HEMMER CHELATE COMPLEXES
WO2008040669A2 (en) 2006-10-02 2008-04-10 Janssen Pharmaceutica N.V. Novel intermediates for the preparation of a glyt1 inhibitor
US7837978B2 (en) 2006-10-13 2010-11-23 Chevron U.S.A. Inc. Process for preparing aluminum-containing molecular sieve SSZ-26
US7786139B2 (en) 2006-11-21 2010-08-31 Omeros Corporation PDE10 inhibitors and related compositions and methods
ES2624791T3 (es) * 2006-11-21 2017-07-17 Omeros Corporation Inhibidores de PDE10 y composiciones y métodos relacionados
PE20081506A1 (es) 2006-12-12 2008-12-09 Infinity Discovery Inc Formulaciones de ansamicina
WO2009008906A2 (en) 2007-02-06 2009-01-15 The Trustees Of The University Of Pennsylvania Therapeutic compounds for blocking dna synthesis of pox viruses
AU2008253803A1 (en) 2007-05-22 2008-11-27 Ultimorphix Technolgies B.V. Tenofovir disoproxil hemi-fumaric acid Co-crystal
EP2017264A1 (de) 2007-07-16 2009-01-21 Bayer Cropscience Ag Substituierte Phenylpropargylverbindungen, Verfahren zu deren Herstellung und deren Verwendung als Herbizide und Pflanzenwachstumsregulatoren
WO2009049022A1 (en) 2007-10-10 2009-04-16 Ore Pharmaceuticals Inc. Method for treatment of pancreatitis
TW200944520A (en) 2008-01-29 2009-11-01 Glaxo Group Ltd Spiro compounds as NPY Y5 receptor antagonists
WO2009143178A2 (en) 2008-05-20 2009-11-26 Omeros Corporation Pde10 inhibitors and related compositions and methods
TWI501965B (zh) 2008-06-20 2015-10-01 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物
US8377930B2 (en) 2008-08-05 2013-02-19 Omeros Corporation PDE10 inhibitors and related compositions and methods
PL2544679T3 (pl) * 2010-03-12 2019-10-31 Omeros Corp Inhibitory PDE10 oraz powiązane kompozycje i sposoby
NZ716462A (en) * 2014-04-28 2017-11-24 Omeros Corp Optically active pde10 inhibitor

Similar Documents

Publication Publication Date Title
JP2016520672A5 (cg-RX-API-DMAC7.html)
JP2010539076A5 (cg-RX-API-DMAC7.html)
JP2010500343A5 (cg-RX-API-DMAC7.html)
JP2012515776A5 (cg-RX-API-DMAC7.html)
JP2014515406A5 (cg-RX-API-DMAC7.html)
JP2019048806A5 (cg-RX-API-DMAC7.html)
JP2010095546A5 (cg-RX-API-DMAC7.html)
JP2012092103A5 (cg-RX-API-DMAC7.html)
JP2013210627A5 (cg-RX-API-DMAC7.html)
JP2015518892A5 (cg-RX-API-DMAC7.html)
JP2017535555A5 (cg-RX-API-DMAC7.html)
JP2015530408A5 (cg-RX-API-DMAC7.html)
JP2010530373A5 (cg-RX-API-DMAC7.html)
JP2013523912A5 (cg-RX-API-DMAC7.html)
JP2014526533A5 (cg-RX-API-DMAC7.html)
JP2012214724A5 (cg-RX-API-DMAC7.html)
JP2019504839A5 (cg-RX-API-DMAC7.html)
JP2012094862A5 (cg-RX-API-DMAC7.html)
JP2017513885A5 (cg-RX-API-DMAC7.html)
JP2014504599A5 (cg-RX-API-DMAC7.html)
JP2017513913A5 (cg-RX-API-DMAC7.html)
JP2015506371A5 (cg-RX-API-DMAC7.html)
RU2019105302A (ru) Борсодержащее соединение
JP2013529723A5 (cg-RX-API-DMAC7.html)
RU2016146118A (ru) Способы и промежуточные соединения для получения ингибитора pde10